PEAK6 Group’s Agios Pharmaceuticals AGIO Stock Holding History

PEAK6 Group’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-34,400	Closed	-$2.81M	–	4239
2018 Q1	$2.81M	Buy	+34,400	New	+$2.66M	0.01%	1153
2017 Q4	–	Sell	-600	Closed	-$40K	–	4030
2017 Q3	$40K	Sell	600 -49,600	-99%	-$2.98M	﹤0.01%	4066
2017 Q2	$2.58M	Buy	+50,200	New	+$2.57M	0.02%	1139
2016 Q1	–	Sell	-200	Closed	-$13K	–	4320
2015 Q4	$13K	Sell	200 -2,900	-94%	-$190K	﹤0.01%	4555
2015 Q3	$219K	Sell	3,100 -42,600	-93%	-$4.16M	﹤0.01%	3654
2015 Q2	$5.08M	Buy	45,700 +40,100	+716%	+$4.32M	0.03%	830
2015 Q1	$528K	Buy	5,600 +500	+10%	+$56K	﹤0.01%	2487
2014 Q4	$571K	Sell	5,100 -2,500	-33%	-$223K	﹤0.01%	2466
2014 Q3	$466K	Buy	+7,600	New	+$328K	﹤0.01%	2537

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PEAK6 Group's AGIO Position: Q2 2018 in Review

PEAK6 Group opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2018: 4,577 shares worth $386K. The stake represents ﹤0.01% of the portfolio and ranks #2798 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in AGIO as recently as Q3 2017.

PEAK6 Group first reported a position in AGIO in Q3 2015 and has held it in 6 quarters since. The position peaked at $541K in Q3 2015. 217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

PEAK6 Group held 4,577 shares of Agios Pharmaceuticals worth $386K as of Q2 2018.
Agios Pharmaceuticals was a new PEAK6 Group position in Q2 2018.
Agios Pharmaceuticals made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2798 holding.
PEAK6 Group first reported a position in Agios Pharmaceuticals in Q3 2015 and has held it in 6 quarters since.
PEAK6 Group's Agios Pharmaceuticals position peaked at $541K in Q3 2015.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.